A non-randomised pilot study of the Solutions for Medication Adherence Problems (S-MAP) intervention in community pharmacies to support older adults adhere to multiple medications

Table 5 DPPR, MPR, Lu item, MARS-5, EQ-5D-5L utility and EQ-VAS scores pre- and post-session 1

	Number of patients	Pre-session 1 median (IQR)	95% confidence intervals for pre-session 1 median	Post-session 1, median (IQR)	95% confidence intervals for post-session 1 median	Z^a	Effect size (r)^b
Primary outcome: dispensing data measures (DPPR, MPR)
DPPR (%)	44	85.2 (72.0-96.7)	73.9-92.9	93.8 (84.8-97.8)	86.8-96.7	−3.80	−0.41
MPR (%)	44	93.8 (82.8-100.0)	88.9-97.5	94.6 (87.8-97.8)	89.7-97.5	−1.28	−0.14
Primary outcome: self-reported adherence
Lu item (%)	36	80 (60-80)	60-80	100 (80-100)	80-100	−3.45	−0.41
MARS-5 total	25	22 (20-23.5)	21-23	24 (24-25)	24-25	−3.12	−0.44
Secondary outcome: EQ-5D-5L
EQ-5D-5L- Utility index	30	0.73 (0.52-0.84)	0.53-0.80	0.74 (0.58-0.84)	0.65-0.77	−0.91	−0.12
EQ-5D-5L-VAS	35	75 (50-83)	60-80	75 (60-85)	65-80	−0.12	−0.01

Key: DPPR daily polypharmacy possession ratio; MARS-5 Medication Adherence Report Scale; MPR medication possession ratio; IQR interquartile range
^aTest statistic for Wilcoxon signed-rank test
^bEffect size (r) calculated using r = Z/√N; where Z is the z score for the Wilcoxon signed-rank test and N is the total number of observations. −0.1 indicates a small effect size, −0.3 indicates a medium effect size and −0.5 indicates a large effect size

ISSN: 2055-5784